Morton Dubin II, a notable partner at Kirkland & Ellis, has earned recognition in the Unrivaled 2025 honors for his exceptional trial work. Dubin stands out for his role in defending Johnson & Johnson in the case Matthey v. Johnson & Johnson, which culminated in a pivotal jury verdict in Florida. The case involved allegations that Johnson & Johnson’s talc-based baby powder was linked to the death of a Sarasota County woman from ovarian cancer in 2019. Dubin’s effective trial strategy underscores his commitment to maintaining jury credibility by focusing on the clear presentation of complex scientific evidence.
The Matthey case presented a multitude of challenges, including the necessity of jury comprehension of various scientific fields such as genetics, epidemiology, and toxicology. Dubin’s structured approach ensured that the jury could navigate this extensive evidence successfully. His commitment to making complex subjects accessible to the jury was central to the defense’s success in disproving claims linking talc to ovarian cancer.
Dubin’s beginnings trace back to his love for debate, and he finds joy in the interplay of core legal skills, psychology, and creativity required in trial law. His philosophy is that each trial is uniquely dynamic, much like an intricate puzzle to solve. This perspective is shared with young lawyers whom he encourages to focus on thematic clarity, foster confidence, and maintain resilience through the uncertainties of trial outcomes.
Taking up the mantle at Kirkland & Ellis, Dubin continues to steer through the demands of high-stakes legal battles with preparation and professionalism, valuing credibility as the cornerstone of persuasion both for juries and judges alike. For a deeper dive into Dubin’s insights and accomplishments, read the full article on Bloomberg Law.